Abiopharma

🔍 Liu Suying (Director)

Company: Mountain Crest Acquisition 6 Corp. (MCAH)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Ordinary shares at $10.0 per share (Direct)
  Date: 2026-05-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 2,982,143.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Acquired 6,250 shares of Rights (Derivative)
  Date: 2026-05-01 | Code: P | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3

Footnotes:

• F1: The reporting person acquired units, consisting of shares and rights.
• F2: The rights automatically convert into one-fourth (1/4) of one ordinary share upon the consummation of the registrant's initial business combination, as described in the registrant's prospectus initially filed with the Securities Exchange Commission on April 6, 2026.
• F3: Dr. Suying Liu controls Mountain Crest Holdings 6 LLC. As such, he may be deemed to have or share beneficial ownership of the securities held directly by Mountain Crest Holdings 6 LLC. Suying Liu disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly